Boan Biotech Announces Retirement of Executive Director Dr. Dou and Strategy Committee Realignment Effective 31 March 2026

Bulletin Express03-31

Shandong Boan Biotechnology Co., Ltd. (Boan Biotech) disclosed that Executive Director, President of Research and Development and Chief Operating Officer Dr. Dou Changlin will retire upon reaching the statutory retirement age. His resignation, which also includes stepping down as chairman of the Strategy Committee, will take effect on 31 March 2026. Dr. Dou confirmed he has no disagreements with the Board and highlighted no other matters requiring shareholder attention. The Board acknowledged his diligent service and contributions to the Group’s growth.

\n\nEffective the same date, Chairlady and Executive Director Ms. Jiang Hua will assume the role of chairlady of the Strategy Committee, while Executive Director Mr. Wang Shenghan will join the committee as a member. Post-adjustment, the Strategy Committee will comprise Ms. Jiang Hua (chairlady), Mr. Wang Shenghan and Professor Shi Luwen.

\n\nAs of 31 March 2026, Boan Biotech’s Board composition is as follows: • Executive Directors: Ms. Jiang Hua, Mr. Wang Shenghan • Non-Executive Directors: Mr. Liu Yuanchong, Ms. Li Li, Mr. Li Shixu • Independent Non-Executive Directors: Professor Shi Luwen, Mr. Dai Jixiong, Dr. Yu Jialin

\n\nThe announcement contains no financial performance metrics or operational forecasts, focusing solely on leadership changes scheduled for 31 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170842678?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 22:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170842678","market":"us","top_or_hot":-1,"title":"Boan Biotech Announces Retirement of Executive Director Dr. Dou and Strategy Committee Realignment Effective 31 March 2026","media":"Bulletin Express","content":"<p>Shandong Boan Biotechnology Co., Ltd. (Boan Biotech) disclosed that Executive Director, President of Research and Development and Chief Operating Officer Dr. Dou Changlin will retire upon reaching the statutory retirement age. His resignation, which also includes stepping down as chairman of the Strategy Committee, will take effect on 31 March 2026. Dr. Dou confirmed he has no disagreements with the Board and highlighted no other matters requiring shareholder attention. The Board acknowledged his diligent service and contributions to the Group’s growth.</p>\n<p>\\n\\nEffective the same date, Chairlady and Executive Director Ms. Jiang Hua will assume the role of chairlady of the Strategy Committee, while Executive Director Mr. Wang Shenghan will join the committee as a member. Post-adjustment, the Strategy Committee will comprise Ms. Jiang Hua (chairlady), Mr. Wang Shenghan and Professor Shi Luwen.</p>\n<p>\\n\\nAs of 31 March 2026, Boan Biotech’s Board composition is as follows:\n• Executive Directors: Ms. Jiang Hua, Mr. Wang Shenghan  \n• Non-Executive Directors: Mr. Liu Yuanchong, Ms. Li Li, Mr. Li Shixu  \n• Independent Non-Executive Directors: Professor Shi Luwen, Mr. Dai Jixiong, Dr. Yu Jialin</p>\n<p>\\n\\nThe announcement contains no financial performance metrics or operational forecasts, focusing solely on leadership changes scheduled for 31 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boan Biotech Announces Retirement of Executive Director Dr. Dou and Strategy Committee Realignment Effective 31 March 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoan Biotech Announces Retirement of Executive Director Dr. Dou and Strategy Committee Realignment Effective 31 March 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-31 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Boan Biotechnology Co., Ltd. (Boan Biotech) disclosed that Executive Director, President of Research and Development and Chief Operating Officer Dr. Dou Changlin will retire upon reaching the statutory retirement age. His resignation, which also includes stepping down as chairman of the Strategy Committee, will take effect on 31 March 2026. Dr. Dou confirmed he has no disagreements with the Board and highlighted no other matters requiring shareholder attention. The Board acknowledged his diligent service and contributions to the Group’s growth.</p>\n<p>\\n\\nEffective the same date, Chairlady and Executive Director Ms. Jiang Hua will assume the role of chairlady of the Strategy Committee, while Executive Director Mr. Wang Shenghan will join the committee as a member. Post-adjustment, the Strategy Committee will comprise Ms. Jiang Hua (chairlady), Mr. Wang Shenghan and Professor Shi Luwen.</p>\n<p>\\n\\nAs of 31 March 2026, Boan Biotech’s Board composition is as follows:\n• Executive Directors: Ms. Jiang Hua, Mr. Wang Shenghan  \n• Non-Executive Directors: Mr. Liu Yuanchong, Ms. Li Li, Mr. Li Shixu  \n• Independent Non-Executive Directors: Professor Shi Luwen, Mr. Dai Jixiong, Dr. Yu Jialin</p>\n<p>\\n\\nThe announcement contains no financial performance metrics or operational forecasts, focusing solely on leadership changes scheduled for 31 March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06955","symbol_name":"博安生物","start_time":0,"source_url":"","article_id":"1170842678","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170842678","pubTimestamp":1774965850,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Boan Biotechnology Co., Ltd. (Boan Biotech) disclosed that Executive Director, President of Research and Development and Chief Operating Officer Dr. Dou Changlin will retire upon reaching...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06955":"博安生物"},"translate_title":"博安生物宣布执行董事窦博士退任及战略委员会调整自2026年3月31日起生效","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06955":1},"content_text":"Shandong Boan Biotechnology Co., Ltd. (Boan Biotech) disclosed that Executive Director, President of Research and Development and Chief Operating Officer Dr. Dou Changlin will retire upon reaching the statutory retirement age. His resignation, which also includes stepping down as chairman of the Strategy Committee, will take effect on 31 March 2026. Dr. Dou confirmed he has no disagreements with the Board and highlighted no other matters requiring shareholder attention. The Board acknowledged his diligent service and contributions to the Group’s growth.\n\\n\\nEffective the same date, Chairlady and Executive Director Ms. Jiang Hua will assume the role of chairlady of the Strategy Committee, while Executive Director Mr. Wang Shenghan will join the committee as a member. Post-adjustment, the Strategy Committee will comprise Ms. Jiang Hua (chairlady), Mr. Wang Shenghan and Professor Shi Luwen.\n\\n\\nAs of 31 March 2026, Boan Biotech’s Board composition is as follows:\n• Executive Directors: Ms. Jiang Hua, Mr. Wang Shenghan  \n• Non-Executive Directors: Mr. Liu Yuanchong, Ms. Li Li, Mr. Li Shixu  \n• Independent Non-Executive Directors: Professor Shi Luwen, Mr. Dai Jixiong, Dr. Yu Jialin\n\\n\\nThe announcement contains no financial performance metrics or operational forecasts, focusing solely on leadership changes scheduled for 31 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170842678","isCrawlerRequest":true}